OAKTREE CAPITAL MANAGEMENT LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$12,829,000
+285.7%
12,663,000
+287.4%
0.15%
+325.7%
Q1 2022$3,326,000
+49.9%
3,269,000
+63.4%
0.04%
-16.7%
Q2 2019$2,219,000
-76.5%
2,000,000
-75.6%
0.04%
-66.9%
Q3 2018$9,454,000
+175.7%
8,200,000
+138.0%
0.13%
+164.6%
Q2 2018$3,429,000
-60.8%
3,445,000
-63.4%
0.05%
-65.5%
Q1 2018$8,757,000
+18.1%
9,400,000
-1.2%
0.14%
+19.8%
Q4 2017$7,417,000
-11.9%
9,510,000
-8.2%
0.12%
-7.9%
Q3 2017$8,417,000
+10.5%
10,355,000
+6.8%
0.13%
+0.8%
Q2 2017$7,617,000
+350.4%
9,700,000
+273.1%
0.12%
+400.0%
Q1 2017$1,691,0002,600,0000.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$31,610,0000.98%
Opti Capital Management, LP 8,000,000$8,206,0000.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,076,0000.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$15,848,0000.31%
CSS LLC/IL 7,007,000$7,112,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 17,479,000$17,762,0000.17%
LMR Partners LLP 9,500,000$9,933,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,672,000$4,858,0000.11%
Verition Fund Management LLC 8,091,000$8,233,0000.10%
Aequim Alternative Investments LP 2,000,000$2,035,0000.05%
View complete list of PTC THERAPEUTICS INC shareholders